| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.05. | Aileron Therapeutics, Inc.: Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights | 53 | GlobeNewswire (Europe) | Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated... ► Artikel lesen | |
| 15.05. | Aileron Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Aileron Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.05. | Aileron Therapeutics, Inc.: Aileron Therapeutics to Present at Two Upcoming Investor Conferences | 1 | GlobeNewswire (USA) | ||
| 04.05. | Aileron Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview | 1 | Reuters | ||
| 03.05. | Aileron Therapeutics, Inc.: Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million | 2 | GlobeNewswire (USA) | ||
| 01.05. | Aileron Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 01.05. | Aileron Therapeutics, Inc.: Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million | 1 | GlobeNewswire (USA) | ||
| 01.05. | Aileron Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.05. | Aileron Therapeutics, Inc.: Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) | 31 | GlobeNewswire (Europe) | Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and increased the expression of... ► Artikel lesen | |
| 29.04. | Aileron Therapeutics, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 16.04. | Aileron Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 15.04. | Aileron Therapeutics, Inc.: Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | 378 | GlobeNewswire (Europe) | Topline results from Phase 1b study of LTI-03, a novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected to be reported in the third quarter of... ► Artikel lesen | |
| 15.04. | Aileron Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.04. | Aileron Therapeutics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 01.04. | Aileron Therapeutics, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 4 | SEC Filings | ||
| 29.03. | AILERON THERAPEUTICS INC - 8-K, Current Report | 2 | SEC Filings | ||
| 18.03. | Aileron Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview | 2 | Reuters | ||
| 15.03. | AILERON THERAPEUTICS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 29.02. | AILERON THERAPEUTICS INC - 8-K, Current Report | 2 | SEC Filings |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 4.362 |
| GAMESTOP | 3.476 |
| NVIDIA | 3.155 |
| EVOTEC | 2.977 |
| TUI | 2.000 |
| BAYER | 1.584 |
| BIONTECH | 1.163 |
| PLUG POWER | 1.110 |
| RHEINMETALL | 1.036 |
| VOLKSWAGEN | 928 |
| DEUTSCHE LUFTHANSA | 901 |
| SUPER MICRO COMPUTER | 822 |
| SIEMENS ENERGY | 786 |
| BYD | 761 |
| MERCEDES-BENZ | 739 |
| COMMERZBANK | 683 |
| RWE | 670 |
| AIXTRON SE | 655 |
| HEIDELBERGER DRUCK | 625 |
| DEUTSCHE BANK | 610 |
| RENK GROUP | 606 |
| TESLA | 600 |
| BASF | 566 |
| NORDEX | 564 |
| AMC ENTERTAINMENT | 523 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
